BioLargo, Inc. Files Current 8-K Report

Ticker: BLGO · Form: 8-K · Filed: Jul 23, 2025 · CIK: 880242

Sentiment: neutral

Topics: 8-K, filing, corporate-info

Related Tickers: BLGO

TL;DR

BioLargo filed an 8-K on 7/23/25, confirming their HQ address in Westminster, CA.

AI Summary

On July 23, 2025, BioLargo, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 14921 Chestnut St., Westminster, California, 92683. The report is a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Why It Matters

This filing serves as an official notification to the SEC and the public about the company's operational and administrative details, including its principal executive office location.

Risk Assessment

Risk Level: low — This filing is a routine administrative update and does not contain information that suggests significant new risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by BioLargo, Inc.?

The primary purpose is to serve as a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating the date of the earliest event reported and confirming the company's principal executive offices.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on July 23, 2025.

What is the confirmed address of BioLargo, Inc.'s principal executive offices?

The confirmed address of BioLargo, Inc.'s principal executive offices is 14921 Chestnut St., Westminster, California, 92683.

Under which sections of the Securities Exchange Act of 1934 is this report filed?

This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is BioLargo, Inc.'s state of incorporation and IRS Employer Identification Number?

BioLargo, Inc. is incorporated in Delaware and its IRS Employer Identification Number is 65-0159115.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding BIOLARGO, INC. (BLGO).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing